1. 148 Senticol III: international validation study of sentinel node biopsy in early cervical cancer. A gineco, engot and gcig study. (18th September 2019) Authors: Lecuru, F; Mc Comack, M; Hillemans, P; Anota, A; Leitao, M; Sweemer, R; Fujiwara, K; Mathevet, P; Zanagnolo, V; Raza Mirza, M; Ferron, G; Plante, M; Balaya, V Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 164 ENGOT-cx11/GOG 3047/KEYNOTE-A18: a phase 3, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. (13th November 2020) Authors: Lorusso, D; Colombo, N; Coleman, R; Randall, L; Duska, L; Xiang, Y; Hasegawa, K; Nogueira-Rodrigues, A; Cibula, D; Raza Mirza, M; You, B; Oaknin, A; Christiaens, M; Taskiran, C; Sehouli, J; Korach, J; Martin, C; Keefe, S; Puglisi, M; Pignata, S Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗